Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Assembly Biosciences (ASMB) Asset Utilization Ratio (2017 - 2025)

Assembly Biosciences has reported Asset Utilization Ratio over the past 9 years, most recently at 0.29 for Q4 2025.

  • Quarterly results put Asset Utilization Ratio at 0.29 for Q4 2025, up 11.8% from a year ago — trailing twelve months through Dec 2025 was 0.29 (up 11.8% YoY), and the annual figure for FY2025 was 0.38, up 72.25%.
  • Asset Utilization Ratio for Q4 2025 was 0.29 at Assembly Biosciences, up from 0.23 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for ASMB hit a ceiling of 0.37 in Q2 2025 and a floor of 0.03 in Q4 2021.
  • Median Asset Utilization Ratio over the past 5 years was 0.18 (2024), compared with a mean of 0.17.
  • Peak annual rise in Asset Utilization Ratio hit 439.49% in 2021, while the deepest fall reached 89.65% in 2021.
  • Assembly Biosciences' Asset Utilization Ratio stood at 0.03 in 2021, then skyrocketed by 43.72% to 0.04 in 2022, then soared by 86.08% to 0.08 in 2023, then skyrocketed by 241.95% to 0.26 in 2024, then rose by 11.8% to 0.29 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.29 (Q4 2025), 0.23 (Q3 2025), and 0.37 (Q2 2025) per Business Quant data.